Clinical Trials
5 trialsNCT06276933 2024-02-26
A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Tongji University
Phase 4 Not yet recruiting
NCT04291092 2021-09-10
Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT04425135 2020-06-11
Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC
The First Affiliated Hospital of Xiamen University
Phase 2 Unknown
NCT04201990 2019-12-17
CCA-MPLC
Guangzhou Institute of Respiratory Disease
Phase 1/2 Unknown
NCT04108013 2019-09-27
A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC
Xuanwu Hospital, Beijing
Phase 2 Unknown